Brave Asset Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-4,600
| Closed | -$36K | – | 409 |
|
|
2016
Q2 | $36K | Hold |
4,600
| – | – | 0.02% | 249 |
|
|
2016
Q1 | $36K | Hold |
4,600
| – | – | 0.03% | 248 |
|
|
2015
Q4 | $50K | Hold |
4,600
| – | – | 0.03% | 220 |
|
|
2015
Q3 | $32K | Sell |
4,600
-9,500
| -67% | -$66.1K | 0.02% | 249 |
|
|
2015
Q2 | $125K | Buy |
14,100
+4,000
| +40% | +$35.5K | 0.09% | 155 |
|
|
2015
Q1 | $100K | Buy |
10,100
+6,100
| +153% | +$60.4K | 0.07% | 169 |
|
|
2014
Q4 | $49K | Hold |
4,000
| – | – | 0.04% | 228 |
|
|
2014
Q3 | $40K | Hold |
4,000
| – | – | 0.03% | 237 |
|
|
2014
Q2 | $30K | Hold |
4,000
| – | – | 0.02% | 268 |
|
|
2014
Q1 | $13K | Hold |
4,000
| – | – | 0.01% | 333 |
|
|
2013
Q4 | $13K | Buy |
+4,000
| New | +$13K | 0.01% | 325 |
|